chrX-57286924-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_174912.4(FAAH2):āc.99T>Cā(p.Gly33=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 1,201,299 control chromosomes in the GnomAD database, including 45,773 homozygotes. There are 111,397 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.45 ( 11426 hom., 13405 hem., cov: 21)
Exomes š: 0.27 ( 34347 hom. 97992 hem. )
Consequence
FAAH2
NM_174912.4 synonymous
NM_174912.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.539
Genes affected
FAAH2 (HGNC:26440): (fatty acid amide hydrolase 2) This gene encodes a fatty acid amide hydrolase that shares a conserved protein motif with the amidase signature family of enzymes. The encoded enzyme is able to catalyze the hydrolysis of a broad range of bioactive lipids, including those from the three main classes of fatty acid amides; N-acylethanolamines, fatty acid primary amides and N-acyl amino acids. This enzyme has a preference for monounsaturated acyl chains as a substrate. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant X-57286924-T-C is Benign according to our data. Variant chrX-57286924-T-C is described in ClinVar as [Benign]. Clinvar id is 3056042.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chrX-57286924-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.539 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.879 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAAH2 | NM_174912.4 | c.99T>C | p.Gly33= | synonymous_variant | 1/11 | ENST00000374900.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAAH2 | ENST00000374900.5 | c.99T>C | p.Gly33= | synonymous_variant | 1/11 | 1 | NM_174912.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.452 AC: 49239AN: 108937Hom.: 11414 Cov.: 21 AF XY: 0.426 AC XY: 13345AN XY: 31303
GnomAD3 genomes
AF:
AC:
49239
AN:
108937
Hom.:
Cov.:
21
AF XY:
AC XY:
13345
AN XY:
31303
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.353 AC: 61289AN: 173775Hom.: 9996 AF XY: 0.324 AC XY: 19122AN XY: 59067
GnomAD3 exomes
AF:
AC:
61289
AN:
173775
Hom.:
AF XY:
AC XY:
19122
AN XY:
59067
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.274 AC: 299744AN: 1092309Hom.: 34347 Cov.: 32 AF XY: 0.273 AC XY: 97992AN XY: 358655
GnomAD4 exome
AF:
AC:
299744
AN:
1092309
Hom.:
Cov.:
32
AF XY:
AC XY:
97992
AN XY:
358655
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.452 AC: 49314AN: 108990Hom.: 11426 Cov.: 21 AF XY: 0.427 AC XY: 13405AN XY: 31366
GnomAD4 genome
AF:
AC:
49314
AN:
108990
Hom.:
Cov.:
21
AF XY:
AC XY:
13405
AN XY:
31366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FAAH2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 14, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at